Analysts Offer Insights on Healthcare Companies: Insmed (INSM) and Roche Holding AG (OtherRHHVF)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Insmed (INSM – Research Report) and Roche Holding AG (RHHVF – Research Report).
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Insmed (INSM)
TD Cowen analyst Ritu Baral maintained a Buy rating on Insmed today and set a price target of $241.00. The company’s shares closed last Wednesday at $155.89.
According to TipRanks.com, Baral is a top 100 analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Insmed with a $220.75 average price target, which is a 35.9% upside from current levels. In a report issued on January 25, Roth MKM also initiated coverage with a Buy rating on the stock with a $212.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Roche Holding AG (RHHVF)
In a report released today, Richard Vosser from J.P. Morgan maintained a Hold rating on Roche Holding AG, with a price target of CHF350.00. The company’s shares closed last Wednesday at $424.00.
According to TipRanks.com, Vosser is a 4-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Roche Holding AG with a $439.28 average price target, a -1.6% downside from current levels. In a report issued on January 15, Goldman Sachs also upgraded the stock to Hold with a CHF365.00 price target.
